A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.

While the fianlimab arm showed a numerical improvement in progression-free survival, the difference was not statistically ...

FDA rejects melanoma drug vusolimogene with nivolumab, citing insufficient evidence from Replimune’s phase 2 and 3 trials.

I've always been vigilant about monitoring my skin for unusual spots since I have a family history of melanoma in addition to ...

SUPRAME Phase 3 interim and final analysis for PRAME cell therapy, anzu-cel, expected to be triggered in 2026, advancing toward the Company’s ...

Julian Lennon, eldest son of the late Beatle John, revealed he has been diagnosed with coronary heart disease and ...

Phase 3 CoMpass trial advancing toward enrollment completion, supporting 2H 2027 topline dataNatalie Holles appointed Chief Executive Officer and ...

During Dr. Martin Makary’s tenure as commissioner, the FDA faced pushback over high-profile drug rejections for Replimune and ...

Makary's tenure was marked by internal dysfunction at the FDA, leadership turmoil and mounting backlash from drugmakers and physicians on regulatory decisions.

Phase 3 CoMpass trial advancing toward enrollment completion, supporting 2H 2027 topline data Natalie Holles appointed Chief Executive Officer and President and member of the Board of Directors Streng ...